- 1M+ patient rides facilitated monthly
- 99% ride fulfillment rate with <0.25% grievance rate
- 2,000% revenue growth over 5 years
Experts would likely conclude that SafeRide Health has successfully demonstrated how technology-driven innovation in non-emergency medical transportation (NEMT) can address critical healthcare access challenges while achieving strong financial performance and scalability.
SafeRide Health: Driving Profit by Solving Healthcare's Access Crisis
SAN ANTONIO, TX – August 11, 2026 – For the second consecutive year, San Antonio-based SafeRide Health has secured a coveted spot on the Inc. 5000 list of America’s fastest-growing private companies. Landing at No. 756, this recognition is more than a vanity metric; it’s a powerful signal that the company has cracked a critical code, transforming a long-neglected corner of the healthcare system into a profitable, high-growth enterprise. By facilitating over a million patient rides each month, SafeRide has demonstrated a scalable model for solving one of healthcare's most persistent challenges: getting patients to their appointments.
While many companies chase growth, SafeRide’s journey is a masterclass in translating a compelling mission into commercial success. The company, which turned profitable in 2024, has not only navigated the complex world of non-emergency medical transportation (NEMT) but is actively redefining it. This isn't just about giving people a lift; it's about leveraging technology to dismantle barriers to care for the nation's most vulnerable populations, proving that purpose-driven innovation can be a powerful engine for profit.
The Technology Engine Disrupting a Legacy Industry
The NEMT industry has historically been plagued by inefficiency. Characterized by fragmented networks, paper-based processes, and a lack of transparency, the legacy model often resulted in missed appointments, frustrated patients, and wasted healthcare dollars. This is the landscape SafeRide Health set out to disrupt a decade ago.
At the core of its success is a proprietary technology platform built on an “AI-first innovation strategy.” Instead of relying on outdated call centers and manual dispatching, SafeRide orchestrates a nationwide network of credentialed transportation providers—from traditional medical vehicles to rideshare and public transit—through a single, intelligent system. This platform provides real-time eligibility verification, ensuring a patient is approved for a ride, and employs smart trip orchestration to match the member’s specific needs (such as mobility requirements or caregiver accompaniment) with the most appropriate and cost-effective transport option.
The results of this tech-forward approach are stark. SafeRide boasts an industry-leading 99% ride fulfillment rate and a grievance rate below 0.25%. For health plans, this translates into reliability and predictability. For patients—many of whom are managing chronic conditions like kidney failure or cancer—it means the difference between receiving life-sustaining treatment and facing a health crisis. This operational excellence, driven by technology, is the foundational layer of the company's commercial viability.
From Cost Center to Care Lever
SafeRide’s commercialization strategy hinges on repositioning NEMT from a burdensome cost center into a strategic lever for improving health outcomes and member experience. The company’s primary clients are Medicaid and Medicare Advantage plans, which are increasingly focused on addressing the Social Determinants of Health (SDoH)—the non-medical factors like transportation that have a profound impact on a person's well-being.
“Since day one, our goal has been to disrupt the legacy NEMT industry, using technology and member-first models to make a meaningful impact on patient lives and payer programs,” said Robbins Schrader, CEO and co-founder of SafeRide Health. “Our ongoing success is a testament to that vision, and to the strength of the innovation and partnerships we’ve achieved.”
This vision resonates with payers who understand that a missed $50 ride can lead to a $2,000 emergency room visit. By ensuring a patient reliably gets to their dialysis or chemotherapy appointment, SafeRide helps its partners prevent costly downstream health complications. This value proposition has enabled the company to forge partnerships with leading health plans across the country, including a recent collaboration with Community First Health Plans to overhaul its member transportation program. By proving a direct link between their service and better health economics, SafeRide has successfully unlocked a massive and growing market.
Charting the Path to Profitability and Scale
SafeRide's financial performance validates its strategic approach. The company's claim of over 2,000% revenue growth in the past five years is staggering, built upon the three-year growth rate of over 1,100% that earned it a high rank on the 2025 Inc. 5000 list. Achieving this while reaching profitability in 2024—a significant milestone for any high-growth tech company—demonstrates a disciplined and sustainable business model.
Founded in 2016, the company is now celebrating its 10th year by operating at a national scale. Its platform is active in all 50 states, and it projects it will facilitate over 12 million rides in 2026 alone. This growth is not just a national story; it's a local one. SafeRide ranks as the No. 5 fastest-growing private business in the San Antonio metro area, cementing its status as a key player in the region's burgeoning tech scene.
This journey from a startup with a vision to a profitable, national leader in a decade illustrates a clear path from prototype to profit. By identifying a critical, systemic problem and building a robust, technology-driven solution, SafeRide has created immense value for patients, payers, and now, its own bottom line. The company’s ability to attract Series C funding and earn accolades as a top workplace further underscores the strength of its foundation and its readiness for the next phase of growth.
Topics & Related
Value-Based Care
📝 This article is still being updated
Are you a relevant expert who could contribute your opinion or insights to this article? We'd love to hear from you. We will give you full credit for your contribution.
Contribute Your Expertise →